Your browser doesn't support javascript.
loading
Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate.
Brünnert, Daniela; Seupel, Raina; Goyal, Pankaj; Bach, Matthias; Schraud, Heike; Kirner, Stefanie; Köster, Eva; Feineis, Doris; Bargou, Ralf C; Schlosser, Andreas; Bringmann, Gerhard; Chatterjee, Manik.
Afiliación
  • Brünnert D; University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, 97080 Würzburg, Germany.
  • Seupel R; Institute of Organic Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Goyal P; Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Bandar Sindri, Kishangarh 305817, India.
  • Bach M; Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, 97080 Würzburg, Germany.
  • Schraud H; University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, 97080 Würzburg, Germany.
  • Kirner S; University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, 97080 Würzburg, Germany.
  • Köster E; Institute of Organic Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Feineis D; Institute of Organic Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Bargou RC; University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, 97080 Würzburg, Germany.
  • Schlosser A; Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, 97080 Würzburg, Germany.
  • Bringmann G; Institute of Organic Chemistry, University of Würzburg, 97074 Würzburg, Germany.
  • Chatterjee M; University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, 97080 Würzburg, Germany.
Pharmaceuticals (Basel) ; 16(8)2023 Aug 18.
Article en En | MEDLINE | ID: mdl-37631095

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza